卒中专家对急性串联闭塞最佳管理缺乏共识
该调查于2017年9月向加拿大卒中联盟等机构及ESCAPE试验合作者发放在线问卷,分析162名卒中专家的应答。结果显示59.3%的受访者将急性颈内动脉支架植入视为治疗选择,40.7%从不使用;69.8%认为最佳急性管理存在不确定性,54.3%愿意将患者纳入随机试验。
要点
- 59.3%的卒中专家考虑急性颈内动脉支架植入,40.7%从不使用。
- 69.8%的受访者认为串联闭塞最佳急性管理存在不确定性。
- 54.3%的专家愿意将患者纳入相关随机试验。
核心结论
- 急性串联闭塞的临床实践高度变异,学界存在社区均势,凸显开展随机试验评估急性颈内动脉支架植入获益的重要性。
研究设计与样本
- 在线问卷调查,于2017年9月发放,2个月后提取数据,采用描述性统计分析。
- 调查对象为加拿大卒中联盟、加拿大介入神经组、血管与介入神经病学会及ESCAPE试验国际合作者中的卒中专家。
- 共分析162名卒中专家的应答,其中卒中医生65名(40.1%),神经介入医生74名(45.7%)。
- 受访者来自加拿大95名(58.6%)、美国42名(25.9%)及其他国家25名(15.4%)。
主要发现
- 96名(59.3%)受访者将急性颈内动脉支架植入视为治疗选择,66名(40.7%)从不使用。
- 113名(69.8%)受访者同意串联闭塞患者的最佳急性管理存在不确定性。
- 88名(54.3%)受访医生愿意将患者纳入针对该问题的随机试验。
临床怎么用
- 调查结果提示急性串联闭塞的管理决策存在较大分歧,临床医生应关注相关随机试验证据。
- 多数专家认为存在临床均势,支持通过随机试验比较急性颈内动脉支架植入与保守策略的获益。
局限性
- 原文未明确报告调查的应答率及无应答偏倚。
- 样本以加拿大和美国专家为主,可能限制结果的外推性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- In patients with acute stroke caused by tandem occlusion, the benefit of immediate revascularization (stenting) of the cervical internal carotid artery lesion during endovascular thrombectomy is uncertain. We sought to determine current practice patterns and whether consensus existed among physicians with stroke expertise. Methods- We distributed an online survey to stroke experts affiliated with the Canadian Stroke Consortium, the Canadian Interventional Neuro Group, the Society of Vascular and Interventional Neurology, and international ESCAPE trial (Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion With Emphasis on Minimizing CT to Recanalization Times) collaborators. Questions were based on clinical scenarios, and multiple choice responses across a Likert-type scale were provided. The survey was sent out in September 2017. After 2 months, data were extracted and then analyzed using descriptive statistics. Results- Responses from 162 stroke experts were analyzed; most were stroke physicians (n=65, 40.1%) and neurointerventionalists (n=74, 45.7%), from Canada (n=95, 58.6%), the United States (n=42, 25.9%), and other countries (n=25, 15.4%). Over half (n=96, 59.3%) of respondents consider acute stenting of the cervical internal carotid artery as a treatment option, whereas 40.7% (n=66) would never use it. Most respondents (n=113, 69.8%) agree that there exists uncertainty about the optimal acute management of patients with tandem occlusion. A majority (n=88, 54.3%) of physicians surveyed would include patients in a randomized trial addressing this question. Conclusions- This survey shows high variability in practice about acute management of tandem occlusion. The existence of community equipoise underscores the importance of a randomized trial evaluating the benefit of acute internal carotid artery stenting in patients with tandem occlusion undergoing endovascular thrombectomy.
引用
- Jacquin G, Poppe AY, Labrie M, et al. Lack of Consensus Among Stroke Experts on the Optimal Management of Patients With Acute Tandem Occlusion. Stroke. 2019. PMID: 30890115. doi:10.1161/STROKEAHA.118.023758
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。